The largest database of trusted experimental protocols

3 protocols using dasatinib

1

Tetramer Staining Protocol for T Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tetramer staining was adapted from Tungatt et al. (Tungatt et al., 2015 (link)). Cells were treated with dasatinib (AdooQ Bioscience) at a final concentration of 50 nM for 30 minutes at 37°C. PE- and APC-labeled tetramers were added directly to dasatinib-treated cells (without washing) at a final concentration of 12.5–100 nM for 1 hour at room temperature. Cells were washed and incubated with unconjugated mouse anti-PE antibody (clone PE001, Biolegend) and mouse anti-APC antibody (clone APC003, Biolegend) at a concentration of 10 µg/mL for 20 minutes on ice. Cells were washed and stained for flow cytometric analysis as described below. Staining of cells from Aire+/+ and Aire−/− prostates was performed with 12.5 nM of each tetramer. Staining of cells from TRAMP prostate tumors was performed with 20 nM of each tetramer.
+ Open protocol
+ Expand
2

Dasatinib Inhibits Abelson Tyrosine Kinase in Silkworms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Abelson tyrosine kinase was inhibited by Dasatinib (Adooq Bioscience, Nanjing, China). An amount of 1 mg of Dasatinib was dissolved in 205 mL H2O to prepare the stock solution. The stock solution was diluted to 0.6 nm and smeared on the fresh mulberry leaves. First-day third-instar larvae of B. mori were reared with inhibitor-treated leaves until the wandering stage. The Control group larvae were reared with H2O-treated leaves. Each group had three biological replicates. Each replicate contained thirty larvae. All larvae were taken for the same treatment.
+ Open protocol
+ Expand
3

Cell-based Assay of Multi-Targeted Kinase Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Regorafenib, M-2, M-5, and elacridar were purchased from Toronto Research Chemicals (North York, ON). Ko143 was from Sigma-Aldrich (St. Louis, MO). Imatinib mesylate was from Focus Biomolecules (Plymouth Meeting, PA). Afatinib, bortezomib, cabozantinib, carfilzomib, dabrafenib, dacomitinib, dasatinib, lapatinib, lenvatinib, pazopanib, ponatinib, ruxolitinib, tofacitinib, trametinib, vandetanib, and vemurafenib were from AdooQ Bioscience (Irvine, CA). Sorafenib was from LKT Laboratories Inc. (St. Paul, MN). Sunitinib was from Synkinase Pty Ltd. (San Diego, CA). Crizotinib was from LC Laboratories Inc. (Woburn, MA). Gefitinib and erlotinib were from Cayman Chemical Company (Ann Arbor, MI). Nilotinib was from ChemScene, LLC (Monmouth Junction, NJ). All other chemicals and reagents were of analytical grade and were obtained from commercial sources.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!